We also examined several cell death related markers, including Bax (BCL2-associated X protein), caspase 3 (Casp3) and caspase 8 (Casp8), which confirmed that only Znpp treatment could mitigate melanoma bone metastasis-induced osteocyte death (Fig. S3D). This evidence concerns the gene CASP8 and melanoma.